PH41

ICD-11 MMS 2026-01

Exposure to or harmful effects of undetermined intent of sedative hypnotic drugs or other CNS depressants

Index terms

  • Exposure to or harmful effects of undetermined intent of sedative hypnotic drugs or other CNS depressants
  • Harmful effects of or exposure to sedative-hypnotic drugs, undetermined intent
  • Harmful effects of or exposure to barbiturates, undetermined intent
Show allHide
  • Harmful effects of or exposure to benzodiazepines, undetermined intent
  • Harmful effects of or exposure to cloral derivatives, undetermined intent
  • Harmful effects of or exposure to paraldehyde, undetermined intent
  • Harmful effects of or exposure to bromine compounds, undetermined intent
  • Harmful effects of or exposure to mixed sedatives or hypnotics, not elsewhere classified, undetermined intent
  • Harmful effects of or exposure to anaesthetics or therapeutic gases, undetermined intent
  • Harmful effects of or exposure to anaesthetics or therapeutic gases, nitrous oxide, undetermined intent
  • Harmful effects of or exposure to anaesthetics or therapeutic gases, other inhaled anaesthetics, undetermined intent
  • Harmful effects of or exposure to anaesthetics or therapeutic gases, intravenous anaesthetics, undetermined intent
  • Harmful effects of or exposure to anaesthetics or therapeutic gases, unspecified general anaesthetics, undetermined intent
  • Harmful effects of or exposure to anaesthetics or therapeutic gases, gamma hydroxybutyrate, undetermined intent
  • Harmful effects of or exposure to anaesthetics or therapeutic gases, ketamine, undetermined intent
  • Harmful effects of or exposure to anaesthetics or therapeutic gases, other specified general anaesthetic, undetermined intent
  • Harmful effects of or exposure to anaesthetics or therapeutic gases, local anesthetics,undetermined intent

Exclusions from above levels

  • http://id.who.int/icd/entity/1583926619 – Substances associated with injury or harm in therapeutic use

Sibling codes

  • PH40 – Exposure to or harmful effects of undetermined intent of opioids or related analgesics
  • PH42 – Exposure to or harmful effects of undetermined intent of psychostimulants
  • PH43 – Exposure to or harmful effects of undetermined intent of cannabinoids or hallucinogens
  • PH44 – Exposure to or harmful effects of undetermined intent of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs
  • PH45 – Exposure to or harmful effects of undetermined intent of antidepressants
  • PH46 – Exposure to or harmful effects of undetermined intent of antipsychotics
  • PH47 – Exposure to or harmful effects of undetermined intent of antiepileptics or antiparkinsonism drugs
  • PH48 – Exposure to or harmful effects of undetermined intent of other or unspecified drugs, medicaments or biological substances
  • PH49 – Exposure to or harmful effects of undetermined intent of multiple drugs, medicaments or biological substances

Foundation entity

Exposure to or harmful effects of undetermined intent of sedative hypnotic drugs or other CNS depressants – http://id.who.int/icd/entity/2124471964

Allowed postcoordination axes

Part of: 23: External causes of morbidity or mortality